Table 4.
Medication | Number of cases in total N = 226,266 |
Frequency in total | Number of cases in suspected CAD N = 48,406 |
Frequency of cases in suspected CAD |
---|---|---|---|---|
Adenosine | 50,131 | 22.2% | 30,470 | 62.9% |
Regadenoson | 6384 | 2.8% | 4106 | 8.5% |
Dobutamine | 913 | 0.4% | 597 | 1.2% |
Sedation | 483 | 0.2% | 107 | 0.2% |
Nitrates | 254 | 0.1% | 145 | 0.3% |
Beta-blockers—intravenous | 108 | 0.05% | 56 | 0.1% |
Beta-blockers—oral | 85 | 0.04% | 23 | 0.05% |
Premedication for contrast allergy | 46 | 0.02% | 11 | 0.02% |
Calcium channel blocker | 8 | 0.004% | 4 | 0.01% |
CAD coronary artery disease. N number of patients in category
Medications are not mutually exclusive due to different indications